Scarica l'app Stockscreener
363.04
1.44%
-4.325
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché UTHR Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$367.36
Aprire:
$366.6
Volume 24 ore:
107.07K
Relative Volume:
0.35
Capitalizzazione di mercato:
$16.40B
Reddito:
$2.76B
Utile/perdita netta:
$1.11B
Rapporto P/E:
15.94
EPS:
22.77
Flusso di cassa netto:
$898.10M
1 W Prestazione:
-2.30%
1M Prestazione:
-1.60%
6M Prestazione:
+2.97%
1 anno Prestazione:
+65.19%
Intervallo 1D:
$362.00
$369.00
Intervallo di 1 settimana:
$362.00
$383.50
Portata 52W:
$214.75
$417.81
United Therapeutics Corp Stock (UTHR) Company Profile
Nome
United Therapeutics Corp
Settore
Industria
Telefono
(301) 608-9292
Indirizzo
1000 SPRING ST, SILVER SPRING, MD
Confronta UTHR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
UTHR
United Therapeutics Corp
|
362.12 | 16.40B | 2.76B | 1.11B | 898.10M | 22.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
480.12 | 123.34B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
694.85 | 76.09B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
648.35 | 39.34B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.00 | 32.49B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
116.91 | 28.26B | 3.30B | -501.07M | 1.03B | -2.1146 |
United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-11 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-02-12 | Aggiornamento | Goldman | Sell → Neutral |
| 2024-02-05 | Iniziato | Leerink Partners | Outperform |
| 2023-12-08 | Iniziato | Wells Fargo | Overweight |
| 2022-12-06 | Iniziato | UBS | Buy |
| 2022-12-05 | Iniziato | Goldman | Sell |
| 2022-10-11 | Iniziato | Morgan Stanley | Overweight |
| 2022-09-20 | Reiterato | BofA Securities | Underperform |
| 2022-09-19 | Ripresa | Wedbush | Outperform |
| 2022-02-11 | Iniziato | BTIG Research | Neutral |
| 2021-07-14 | Aggiornamento | Argus | Hold → Buy |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-02-01 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-09-14 | Ripresa | JP Morgan | Overweight |
| 2020-06-25 | Reiterato | H.C. Wainwright | Neutral |
| 2020-03-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-02-27 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2020-01-31 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-12-03 | Iniziato | BofA/Merrill | Underperform |
| 2019-08-01 | Aggiornamento | Jefferies | Underperform → Hold |
| 2019-08-01 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2019-07-01 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-05-17 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-09 | Aggiornamento | Credit Suisse | Underperform → Neutral |
| 2018-10-12 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2018-08-08 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2018-04-03 | Aggiornamento | Credit Suisse | Underperform → Neutral |
| 2018-02-22 | Reiterato | Barclays | Underweight |
| 2018-01-18 | Ripresa | Credit Suisse | Underperform |
| 2017-12-27 | Reiterato | Wedbush | Outperform |
| 2017-04-27 | Reiterato | Wedbush | Outperform |
| 2017-03-30 | Iniziato | UBS | Sell |
| 2017-03-16 | Iniziato | Credit Suisse | Underperform |
Mostra tutto
United Therapeutics Corp Borsa (UTHR) Ultime notizie
United Therapeutics Co. (NASDAQ:UTHR) COO Sells $3,710,500.00 in Stock - MarketBeat
New York State Teachers Retirement System Lowers Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics (UTHR) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Allspring Global Investments Holdings LLC Cuts Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
AustralianSuper Pty Ltd Buys 161,751 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Quent Capital LLC Sells 3,232 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics (UTHR) Projected to Post Earnings on Wednesday - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Empirical Finance LLC - MarketBeat
United Therapeutics president Michael Benkowitz sells shares worth $3.65m - MSN
Empowered Funds LLC Lowers Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Strength Seen in United Therapeutics (UTHR): Can Its 4.9% Jump Turn into More Strength? - Yahoo Finance
United Therapeutics' president sells shares worth $3.48 million - MSN
Insider Selling: United Therapeutics Co. (NASDAQ:UTHR) COO Sells 10,000 Shares of Stock - MarketBeat
United Therapeutics Corporation (UTHR): A Cheap Biotech Stock to Invest In Now - Insider Monkey
United Therapeutics' president sells shares worth $3.48 million By Investing.com - Investing.com Australia
Livforsakringsbolaget Skandia Omsesidigt Has $9.90 Million Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics’ president sells shares worth $3.48 million By Investing.com - Investing.com Nigeria
United Therapeutics Corp. to Host Earnings Call - ACCESS Newswire
Polaris Capital Management LLC Decreases Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics (NASDAQ:UTHR) Sees Strong Trading VolumeWhat's Next? - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Holdings Lowered by Tobam - MarketBeat
United Therapeutics president sells $3.5m in stock - MSN
United Therapeutics scores FDA go-ahead for pig organ transplant clinical trial - Dallas Business Journal
State Street Corp Reduces Stake in United Therapeutics Corp - GuruFocus.com
UTHRUnited Therapeutics Corp Latest Stock News & Market Updates - StockTitan
United Therapeutics president sells $3.5m in stock By Investing.com - Investing.com Australia
China Universal Asset Management Co. Ltd. Purchases 909 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
FDA approves pig organ transplant trials for patients with kidney failure - The Washington Post
United Therapeutics Corporation's (NASDAQ:UTHR) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
US FDA greenlights clinical trails for pig kidney transplants in humans - MSN
Breakthrough IPF Treatment Study Hits Key Milestone: 598 Patients Enrolled in Game-Changing Tyvaso Trial - StockTitan
US approves trials for pig kidney transplants in humans - NewsBytes
Short Interest in United Therapeutics Co. (NASDAQ:UTHR) Declines By 14.3% - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Stock Holdings Raised by Janney Montgomery Scott LLC - MarketBeat
United Therapeutics (NASDAQ:UTHR) Stock Price Down 4.9%Here's What Happened - MarketBeat
United Therapeutics Corp Azioni (UTHR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
United Therapeutics Corp Azioni (UTHR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BENKOWITZ MICHAEL | PRESIDENT AND COO |
Feb 18 '25 |
Sale |
371.05 |
10,000 |
3,710,499 |
0 |
| BENKOWITZ MICHAEL | PRESIDENT AND COO |
Feb 10 '25 |
Option Exercise |
111.00 |
10,000 |
1,110,000 |
7,500 |
| BENKOWITZ MICHAEL | PRESIDENT AND COO |
Feb 10 '25 |
Sale |
348.06 |
10,000 |
3,480,642 |
0 |
| MAHON PAUL A | EVP & GENERAL COUNSEL |
Feb 06 '25 |
Option Exercise |
163.30 |
7,700 |
1,257,410 |
44,410 |
0.28%
0.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):